UNSPSC 51301904: Griseofulvin

This classification denotes an anti-infective agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 32HRV3E3D5. European Medicines Agency schedules Griseofulvin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07966MIG. Griseofulvin generally arises in the molecular formula C17H17CLO6. The term GRISEOFULVIN is an International Non-Proprietary Name or INN. GRISEOFULVIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations schedule griseofulvin under HS 29419000 and SITC 54139. As of Q4 2014, GRISEOFULVIN remains the US FDA Preferred Term for this commodity. Griseofulvin bears US NLM identifiers UMLS ID C0018242 and NCI Concept Code C65819. SMILES: CLC1C2OC3(C(CC(=O)C=C3OC)C)C(=O)C2C(OC)CC1OC.

UNSPSC 51301904 Griseofulvin is a Commodity code that in practice covers pharmaceutical antifungal medications procured by state and local health departments and emergency response agencies for first-aid and medical supply inventory. The recent state and local activity under this code reflects procurement of over-the-counter medications and related medical supplies rather than griseofulvin-specific acquisitions; issuing bodies include city fire-rescue departments and municipal health-response agencies managing broad medical-supply inventories for emergency personnel and community health programs.

The City of Tampa Fire Rescue Department posted ITB 25-P-00157 in April 2026 seeking 32 medical and first-aid supply items including antiseptic sprays, hydrogen peroxide, aspirin, pain relievers, bandages, first aid kits, and emergency blankets, with annual quantities ranging from 1 to 2,700 units per item and a total department budget of $100,000. The City of Tampa solicitation included set-aside provisions for City-certified Small Local Business Enterprises (SLBEs) and Underutilized Woman and Minority Owned Business Enterprises (U-WMBEs), offering a 5% bid discount on the total bid amount, with discounts not to exceed $10,000 for SLBEs and $20,000 for U-WMBEs. All medications required a minimum nine-month expiration date from the date of acceptance, and the procurement anticipated an initial one-year award period with potential for two additional one-year renewals. Recent activity under this code is sparse; the Tampa opportunity represents the primary visible state and local procurement signal for this Commodity code in the current market.